Cephalon | Evaluate

The Mesoblast dream is over

Setbacks still outweigh successes in heart failure

August 25, 2015

Teva’s phase III rejig leaves some unanswered questions

July 08, 2015

Entresto approval revives heart failure sector

April 13, 2015

Cautious Celgene endorsement turns Mesoblast around

October 07, 2014

Teva sharpens focus but deal news lacking

March 05, 2014

Roche breathes easier with positive data for severe asthma drug

February 06, 2014

Circassia resists Nasdaq lure and puts its faith in London

January 23, 2014

Pharma M&A values buoyed by climbing asset prices

October 30, 2013

Teva CEO departure highlights strategic muddle

October 11, 2013

Teva gets uplift from job cuts but needs growth

Load More